DBV Technologies S.A. - American Depositary Shares (DBVT)
22.70
+4.72 (26.25%)
NASDAQ · Last Trade: Dec 17th, 3:37 PM EST
Detailed Quote
Previous Close
17.98
Open
25.30
Bid
22.60
Ask
22.80
Day's Range
20.91 - 26.19
52 Week Range
2.740 - 21.50
Volume
3,655,587
Market Cap
1.25B
PE Ratio (TTM)
-28.02
EPS (TTM)
-0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
486,424
Chart
About DBV Technologies S.A. - American Depositary Shares (DBVT)
Dbv Technologies is a biopharmaceutical company focused on developing innovative therapies for patients with food allergies, particularly peanut allergies. Utilizing its proprietary Systemic Immunotherapy platform, the company aims to create treatments that help desensitize individuals to allergens, ultimately enhancing their quality of life and reducing the risk of severe allergic reactions. By leveraging advanced medical technology and a rigorous clinical development approach, Dbv Technologies strives to bring novel, breakthrough solutions to the field of immunotherapy for food allergies. Read More
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
According to David Fleischer, global principal investigator of the study, the levels of desensitization achieved in the study after one year of treatment are “highly clinically meaningful.”
